NCT04225299 2020-11-13Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerSteba Biotech S.A.Phase 3 Withdrawn
NCT00975429 2015-04-28Study Using WST11 in Patients With Localized Prostate CancerSteba Biotech S.A.Phase 2 Completed86 enrolled